Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Again missing the point. A little over 12M shares were gifted to Novalere irregardless of Fluticare being approved or not. People talk about approval soon but nothing is a guarantee so why change the original agreement. I tried to find out but was given "silent period" (another stalling excuse).

Secondly why announce more dilution (S1/S1a) with the reason being to fund production and distribution of Fluticare when no one knows for certain if and when Fluticare will be approved. Again, this is the second time that excuse was used by the company. My personal feeling is they are bleeding to much cash and wouldn't survive another quarter. The question being why are they bleeding so much cash. Don't forget in a previous Q Damaj had stated they had enough money to last to October 2017.

These two actions were irresponsible if the previous comments by Damaj were accurate and true.